Test Order

Test Order

Mycobacterium TB Complex - Special Study
CDC-10191

Synonym(s)
MTB DST, TB, Tuberculosis, MTBC

CDC Pre-Approval Needed
TB Lab
(404) 639-2455
TBLab@cdc.gov
David Sikes
(404) 639-5489
zrg5@cdc.gov

Supplemental Information Required
Provide the following Specimen Information on the CDC 50.34 Specimen Submission Form: material submitted (bacterial isolate), the specimen source (type), specimen collection date, date sent to CDC, and transport medium/specimen preservative.

Supplemental Form

Performed on Specimens from
Human

Acceptable Sample/ Specimen Type for Testing
To be determined

Minimum Volume Required
To be determined

Collection, Storage, and Preservation of Specimen Prior to Shipping
To be determined

Transport Medium
To be determined

Specimen Labeling
This test order can accommodate diagnostic and non-diagnostic specimens. Testing subject to CLIA regulations requires two primary patient identifiers (e.g., patient first and last name, date of birth, unique patient identifier from time of collection, such as medical record number) on the specimen container and on the test requisition.
       
Research or surveillance specimens may be labeled according to protocol. Labels should not include personally identifiable information. The results reported should NOT be used for diagnosis, treatment, assessment of health or management of the individual patient

Shipping Instructions which Include Specimen Handling Requirements
CDC does not accept routine shipments on weekends or holidays. Please make sure packages arrive Monday – Friday. Ship at room temperature with room-temperature cold packs; must be received within 5 days of shipment. MTBC isolates must be shipped as Infectious substances (Div. 6.2, Class Category A).

Ship To:
[Insert CDC Point of Contact]
Centers for Disease Control and Prevention
RDSB/STATT Unit 29
1600 Clifton Road, NE
Atlanta, GA 30329
[Insert CDC Point of Contact’s Telephone Number]

All samples must be shipped in accordance with all applicable local, state and federal regulations. Upon shipment, submitter should send an email to the CDC POC providing shipping company, shipped date and package tracking number.

Methodology
Includes different methodologies, inclusive of molecular testing for pyrazinamide susceptibility.

Turnaround Time

Interferences & Limitations
To be determined

Additional Information
To be determined

CDC Points of Contact
TB Lab
(404) 639-2455
TBLab@cdc.gov
David Sikes
(404) 639-5489
zrg5@cdc.gov

Version
1.7